David Urso, J.D., is the President and CEO of MEI Pharma, a clinical-stage pharmaceutical company dedicated to developing innovative cancer therapies. With nearly two decades of experience in the life sciences industry, Urso has held various leadership roles within MEI Pharma since joining in 2014. His extensive background in corporate development and legal affairs positions him to steer the company towards continued growth and innovation.
Who is the CEO of MEI Pharma?
With a robust background in both law and molecular biology, David Urso, J.D., has carved a notable path in the life sciences industry. Before joining MEI Pharma, Urso held significant roles such as Chief Operating Officer and General Counsel at Tioga Pharmaceuticals, and Director of Corporate Development and Legal Affairs at DNA Sciences. His career also includes experience as an attorney at prominent law firms and as a bench scientist.
Since joining MEI Pharma in 2014, Urso has been instrumental in shaping the company's strategic direction, culminating in his appointment as President and CEO in June 2023.
Work History
David Urso, J.D., has an extensive work history in the life sciences and legal industries. Here are some of the key positions he has held over the years:
- MEI Pharma - President and CEO (2014 - Present)
- Tioga Pharmaceuticals - Chief Operating Officer and General Counsel
- DNA Sciences - Director of Corporate Development and Legal Affairs
- Various Law Firms - Attorney
- Bench Scientist
Education History
David Urso, J.D., has a distinguished educational background that has significantly contributed to his successful career in the life sciences and legal industries. He earned his Juris Doctor (J.D.) from Harvard Law School, one of the most prestigious law schools in the world. Prior to that, he completed his undergraduate studies at Reed College, where he obtained a bachelor's degree in Molecular Biology and Philosophy. This unique combination of legal and scientific education has equipped Urso with a comprehensive understanding of both the technical and regulatory aspects of the pharmaceutical industry, enabling him to navigate complex challenges and drive innovation at MEI Pharma.
When did David Urso, J.D. join MEI Pharma?
David Urso, J.D., joined MEI Pharma as a senior vice president and general counsel in April 2014. He was appointed President and Chief Executive Officer in June 2023. As of June 2023, David Urso has been with MEI Pharma for approximately 9 years.